Cargando…

Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life

The aim of this observational study was to investigate the influence of different typical preterm diseases on NT-proBNP serum levels in the early postnatal period of life of a preterm infant. NT-proBNP levels of 118 preterm infants born ≤ 31 weeks GA were determined at the first week of life, after...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritz, Agnes-Sophie, Keller, Titus, Kribs, Angela, Hünseler, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353962/
https://www.ncbi.nlm.nih.gov/pubmed/37072630
http://dx.doi.org/10.1007/s00431-023-04973-7
_version_ 1785074817012072448
author Fritz, Agnes-Sophie
Keller, Titus
Kribs, Angela
Hünseler, Christoph
author_facet Fritz, Agnes-Sophie
Keller, Titus
Kribs, Angela
Hünseler, Christoph
author_sort Fritz, Agnes-Sophie
collection PubMed
description The aim of this observational study was to investigate the influence of different typical preterm diseases on NT-proBNP serum levels in the early postnatal period of life of a preterm infant. NT-proBNP levels of 118 preterm infants born ≤ 31 weeks GA were determined at the first week of life, after 4 ± 1 weeks of life, and at a corrected gestational age of 36 + 2 weeks. Relevant complications with a possible influence on NT-proBNP values in the first week of life such as early neonatal infection, hemodynamically significant PDA (hsPDA), early pulmonary hypertension (early PH), and intraventricular hemorrhage (IVH) were evaluated; at 4 ± 1 weeks of life, bronchopulmonary dysplasia (BPD), BPD-related pulmonary hypertension (BPD-associated PH), late infection, IVH, and intestinal complications were evaluated. At a corrected gestational age of 36 ± 2 weeks, we examined the effect of retinopathy of prematurity (ROP), BPD, BPD-associated PH, and late infection on NT-proBNP levels. In the first days of life, only the isolated occurrence of hsPDA resulted in significantly increased NT-proBNP levels. In multiple linear regression analysis, early infection remained independently associated with NT-proBNP levels. At 4 ± 1 weeks of age, the isolated presence of BPD and BPD-related PH resulted in increased levels, and the effect remained significant in the multiple regression analysis. At a corrected gestational age of 36 ± 2 weeks, infants with relevant complications at this final evaluation time tended to have lower NT-proBNP values than our exploratory reference values.    Conlusion: NT-proBNP in the first week of life seems to be mainly influenced by an hsPDA and infection or inflammation. BPD and BPD-related PH are the most important factors influencing NT-proBNP serum levels in the first month of life. When preterm infants reach a corrected GA of 36 ± 2 weeks, chronological age rather than complications of prematurity must be considered when interpreting NT-proBNP levels.
format Online
Article
Text
id pubmed-10353962
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103539622023-07-20 Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life Fritz, Agnes-Sophie Keller, Titus Kribs, Angela Hünseler, Christoph Eur J Pediatr Research The aim of this observational study was to investigate the influence of different typical preterm diseases on NT-proBNP serum levels in the early postnatal period of life of a preterm infant. NT-proBNP levels of 118 preterm infants born ≤ 31 weeks GA were determined at the first week of life, after 4 ± 1 weeks of life, and at a corrected gestational age of 36 + 2 weeks. Relevant complications with a possible influence on NT-proBNP values in the first week of life such as early neonatal infection, hemodynamically significant PDA (hsPDA), early pulmonary hypertension (early PH), and intraventricular hemorrhage (IVH) were evaluated; at 4 ± 1 weeks of life, bronchopulmonary dysplasia (BPD), BPD-related pulmonary hypertension (BPD-associated PH), late infection, IVH, and intestinal complications were evaluated. At a corrected gestational age of 36 ± 2 weeks, we examined the effect of retinopathy of prematurity (ROP), BPD, BPD-associated PH, and late infection on NT-proBNP levels. In the first days of life, only the isolated occurrence of hsPDA resulted in significantly increased NT-proBNP levels. In multiple linear regression analysis, early infection remained independently associated with NT-proBNP levels. At 4 ± 1 weeks of age, the isolated presence of BPD and BPD-related PH resulted in increased levels, and the effect remained significant in the multiple regression analysis. At a corrected gestational age of 36 ± 2 weeks, infants with relevant complications at this final evaluation time tended to have lower NT-proBNP values than our exploratory reference values.    Conlusion: NT-proBNP in the first week of life seems to be mainly influenced by an hsPDA and infection or inflammation. BPD and BPD-related PH are the most important factors influencing NT-proBNP serum levels in the first month of life. When preterm infants reach a corrected GA of 36 ± 2 weeks, chronological age rather than complications of prematurity must be considered when interpreting NT-proBNP levels. Springer Berlin Heidelberg 2023-04-18 2023 /pmc/articles/PMC10353962/ /pubmed/37072630 http://dx.doi.org/10.1007/s00431-023-04973-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Fritz, Agnes-Sophie
Keller, Titus
Kribs, Angela
Hünseler, Christoph
Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title_full Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title_fullStr Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title_full_unstemmed Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title_short Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life
title_sort diseases associated with prematurity in correlation with n-terminal pro-brain natriuretic peptide levels during the early postnatal life
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353962/
https://www.ncbi.nlm.nih.gov/pubmed/37072630
http://dx.doi.org/10.1007/s00431-023-04973-7
work_keys_str_mv AT fritzagnessophie diseasesassociatedwithprematurityincorrelationwithnterminalprobrainnatriureticpeptidelevelsduringtheearlypostnatallife
AT kellertitus diseasesassociatedwithprematurityincorrelationwithnterminalprobrainnatriureticpeptidelevelsduringtheearlypostnatallife
AT kribsangela diseasesassociatedwithprematurityincorrelationwithnterminalprobrainnatriureticpeptidelevelsduringtheearlypostnatallife
AT hunselerchristoph diseasesassociatedwithprematurityincorrelationwithnterminalprobrainnatriureticpeptidelevelsduringtheearlypostnatallife